Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence W Wu

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Biorxiv : the Preprint Server for Biology|December 25, 2025
PKMYT1 inhibition induces DNA damage and synergizes with immune checkpoint blockade in <i>CCNE1</i> -amplified gastroesophageal adenocarcinomaSungjoo Jang, Lawrence W Wu, Jimyung Park, et al.
Immunotherapy|May 8, 2025
Validating Khorana Risk Score in gastric cancer patients on immune checkpoint inhibitors and chemotherapyJunmin Song, Ahmed Ashraf Morgan, Jaeun Ahn, et al.
NPJ Precision Oncology|July 17, 2025
Multi-omic characterization of early-onset esophagogastric cancerLawrence W Wu, Sachin Kumar Deshmukh, Sharon Wu, et al.
JCO Precision Oncology|September 11, 2020
Durable Clinical Response to Larotrectinib in an Adolescent Patient With an Undifferentiated Sarcoma Harboring an <i>STRN</i>-<i>NTRK2</i> FusionLawrence W Wu, Tara Pavlock, Alison Patterson, et al.
Annals of Surgery|September 4, 2024
Patient-derived Organoid Pharmacotyping As A Predictive Tool for Therapeutic Selection in Pancreatic Ductal AdenocarcinomaNorman G Nicolson, Joseph A Tandurella, Lawrence W Wu, et al.
Oncotarget|April 28, 2017
Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cellsMarianna Vitiello, Andrea Tuccoli, Romina D'Aurizio, et al.
Nature|September 28, 2017
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomasHezhe Lu, Shujing Liu, Gao Zhang, et al.
Nature|December 12, 2018
Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomasHezhe Lu, Shujing Liu, Gao Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2018
Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant MelanomaGao Zhang, Lawrence W Wu, Ilgen Mender, et al.
Cancer Research|August 31, 2021
Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy ResistanceJianglan Liu, Vito W Rebecca, Andrew V Kossenkov, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Biorxiv : the Preprint Server for Biology|December 25, 2025
PKMYT1 inhibition induces DNA damage and synergizes with immune checkpoint blockade in <i>CCNE1</i> -amplified gastroesophageal adenocarcinomaSungjoo Jang, Lawrence W Wu, Jimyung Park, et al.
Immunotherapy|May 8, 2025
Validating Khorana Risk Score in gastric cancer patients on immune checkpoint inhibitors and chemotherapyJunmin Song, Ahmed Ashraf Morgan, Jaeun Ahn, et al.
NPJ Precision Oncology|July 17, 2025
Multi-omic characterization of early-onset esophagogastric cancerLawrence W Wu, Sachin Kumar Deshmukh, Sharon Wu, et al.
JCO Precision Oncology|September 11, 2020
Durable Clinical Response to Larotrectinib in an Adolescent Patient With an Undifferentiated Sarcoma Harboring an <i>STRN</i>-<i>NTRK2</i> FusionLawrence W Wu, Tara Pavlock, Alison Patterson, et al.
Annals of Surgery|September 4, 2024
Patient-derived Organoid Pharmacotyping As A Predictive Tool for Therapeutic Selection in Pancreatic Ductal AdenocarcinomaNorman G Nicolson, Joseph A Tandurella, Lawrence W Wu, et al.
Oncotarget|April 28, 2017
Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cellsMarianna Vitiello, Andrea Tuccoli, Romina D'Aurizio, et al.
Nature|September 28, 2017
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomasHezhe Lu, Shujing Liu, Gao Zhang, et al.
Nature|December 12, 2018
Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomasHezhe Lu, Shujing Liu, Gao Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2018
Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant MelanomaGao Zhang, Lawrence W Wu, Ilgen Mender, et al.
Cancer Research|August 31, 2021
Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy ResistanceJianglan Liu, Vito W Rebecca, Andrew V Kossenkov, et al.
Pageof 2